1. Home
  2. DYAI vs GROW Comparison

DYAI vs GROW Comparison

Compare DYAI & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • GROW
  • Stock Information
  • Founded
  • DYAI 1979
  • GROW 1968
  • Country
  • DYAI United States
  • GROW United States
  • Employees
  • DYAI N/A
  • GROW N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • GROW Investment Managers
  • Sector
  • DYAI Health Care
  • GROW Finance
  • Exchange
  • DYAI Nasdaq
  • GROW Nasdaq
  • Market Cap
  • DYAI 28.3M
  • GROW 31.8M
  • IPO Year
  • DYAI 2004
  • GROW N/A
  • Fundamental
  • Price
  • DYAI $0.99
  • GROW $2.48
  • Analyst Decision
  • DYAI Strong Buy
  • GROW
  • Analyst Count
  • DYAI 1
  • GROW 0
  • Target Price
  • DYAI $6.00
  • GROW N/A
  • AVG Volume (30 Days)
  • DYAI 62.0K
  • GROW 43.4K
  • Earning Date
  • DYAI 08-12-2025
  • GROW 09-09-2025
  • Dividend Yield
  • DYAI N/A
  • GROW 3.65%
  • EPS Growth
  • DYAI N/A
  • GROW N/A
  • EPS
  • DYAI N/A
  • GROW 0.01
  • Revenue
  • DYAI $3,554,344.00
  • GROW $8,932,000.00
  • Revenue This Year
  • DYAI $22.56
  • GROW N/A
  • Revenue Next Year
  • DYAI $30.95
  • GROW N/A
  • P/E Ratio
  • DYAI N/A
  • GROW $225.76
  • Revenue Growth
  • DYAI 57.59
  • GROW N/A
  • 52 Week Low
  • DYAI $0.91
  • GROW $2.02
  • 52 Week High
  • DYAI $2.20
  • GROW $2.73
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 46.85
  • GROW 52.38
  • Support Level
  • DYAI $0.91
  • GROW $2.35
  • Resistance Level
  • DYAI $1.02
  • GROW $2.49
  • Average True Range (ATR)
  • DYAI 0.05
  • GROW 0.09
  • MACD
  • DYAI 0.01
  • GROW -0.02
  • Stochastic Oscillator
  • DYAI 35.07
  • GROW 24.24

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

Share on Social Networks: